These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7522704)

  • 21. [Effectiveness of synthetic opioid peptide dalargin in acute myocardial infarction].
    Golikov AP; Riabinin VA; Zholudev AA; Luk'ianov MM; Avilova OA
    Kardiologiia; 1990 Sep; 30(9):24-7. PubMed ID: 2273732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The mechanism of the antiarrhythmic action of dalargin in experimental myocardial ischemia].
    Maslov LN; Lishmanov IuB
    Eksp Klin Farmakol; 1992; 55(2):25-8. PubMed ID: 1358376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Anti-ischemic effect of the new Soviet drug dalargin].
    Sokolovich GE; Slepushkin VD; Savitskiĭ GG; Zoloev GK; Poiarkov VD
    Voen Med Zh; 1989 Jun; (6):20-2. PubMed ID: 2800394
    [No Abstract]   [Full Text] [Related]  

  • 24. [The restriction of hemodynamic disorders in acute hypoxia and in situ reoxygenation by using the synthetic peptide bioregulator dalargin].
    Pashutin SB
    Biull Eksp Biol Med; 1991 Nov; 112(11):505-7. PubMed ID: 1810489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of dalargin, a synthetic analog of endogenous opioids, on functional indices of isolated rat heart in experimental toxemia in vitro].
    Pashutin SB
    Biull Eksp Biol Med; 1989 Nov; 108(11):533-6. PubMed ID: 2633813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of opiate peptide dalargin and des-Tyr-dalargin on cardiac pump function during ischemia-reperfusion.
    Lasukova TV; Maslov LN; Podoksenov YK; Podoksenov AY; Platonov AA; Ovchinnikov MV; Bespalova ZhD
    Bull Exp Biol Med; 2004 Jan; 137(1):27-30. PubMed ID: 15085238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study of xanthine oxidase activity in the brain tissue after administration of dalargin during myoplegia].
    Korotkina RN; Shloznikov BM; Donich SG; Grebenchikov OA; Sitnikov AV; Karelin AA
    Biull Eksp Biol Med; 1990 Feb; 109(2):145-6. PubMed ID: 2159814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effect of dalargin on the course of experimental cardiac arrhythmias].
    Grekova TI; Reznikov KM; Vinokurova OV; Kireeva AA; Taratinova TI; Nikolaevskiĭ VA; Shchetinkina NA
    Eksp Klin Farmakol; 1994; 57(2):24-6. PubMed ID: 8205043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of a synthetic analogue of leu-enkephalin (Dalargin) in alcohol withdrawal.
    Aliyev NA
    Drug Alcohol Depend; 1992 Aug; 30(3):209-13. PubMed ID: 1327707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The effect of dalargin on systemic hemodynamics and microcirculation in experimental traumatic shock].
    Donskikh EA; Kozhevnikova IM
    Patol Fiziol Eksp Ter; 1989; (1):39-42. PubMed ID: 2717231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevention of infectious complications in heart surgery patients with dalargin].
    Pashutin SB; Zinov'eva TD; Tsygankova LG; Smirnova VI
    Khirurgiia (Mosk); 1993 Nov; (11):55-9. PubMed ID: 8145468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The antioxidant action of dalargin on the liver in experimental acute cholestasis].
    Korotkina RN; Fomchenkov EP; Babkina NV; Andreev VI; Shloznikov BM; Karelin AA
    Patol Fiziol Eksp Ter; 1990; (4):42-4. PubMed ID: 2080086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Blood flow in skin wound tissue and systemic hemodynamics as affected by a collagen-dalargin complex].
    Medvedev OS; Khulup GIa; Spevak SE; Istranov LP; Titov MI
    Biull Eksp Biol Med; 1987 Dec; 104(12):651-4. PubMed ID: 2446676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Use of synthetic analogs of enkephalins as antiatherogenic means].
    Zoloev GK; Slepushkin VD; Argintaev ES; Prum IA; Sokolovich GE
    Biull Eksp Biol Med; 1989 Oct; 108(10):468-70. PubMed ID: 2597763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Dalargin in the treatment of arteriosclerosis obliterans of the lower extremities].
    Dudko VA; Fedorova NA; Didenko VA; Zoloev GK
    Sov Med; 1990; (2):90-2. PubMed ID: 2192476
    [No Abstract]   [Full Text] [Related]  

  • 36. [Antistress and cardioprotective properties of the synthetic analog of endogenous opioids dalargin in experimental burn trauma in rats].
    Pashutin SB
    Patol Fiziol Eksp Ter; 1992; (2):36-8. PubMed ID: 1408391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Actions of dalargin upon single unit activity in the ampullae of Lorenzini of the skate Raja clavata.
    Andrianov GN; Akoev GN; Braun HA; Ryzhova IV; Voigt KH; Sherman NO
    Neuroreport; 1993 Jan; 4(1):53-4. PubMed ID: 8384018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The mechanism of the action of dalargin in experimental myocardial ischemia].
    Mikhaĭlova SD; Storozhakov GI; Bebiakova NA; Glushchenko NV; Semushkina TM
    Biull Eksp Biol Med; 1992 Oct; 114(10):345-7. PubMed ID: 1288681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapy in the cardiodepressive action of bacterial and toxic shock using the regulatory opioid peptide dalargin in rats].
    Pashutin SB
    Patol Fiziol Eksp Ter; 1991; (4):18-20. PubMed ID: 1798642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of dalargin on the processes of cell division in the gastric epithelium during stress].
    Timoshin SS; Shvets SI; Murzina NB; Berezina GP
    Biull Eksp Biol Med; 1990 Oct; 110(10):399-401. PubMed ID: 2279093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.